首页> 外文期刊>Molecules >Novel Bioactive Paulomycin Derivatives Produced by Streptomyces albus J1074
【24h】

Novel Bioactive Paulomycin Derivatives Produced by Streptomyces albus J1074

机译:由白色链霉菌J1074生产的新型生物活性保乐霉素衍生物

获取原文
           

摘要

Four novel paulomycin derivatives have been isolated from S. albus J1074 grown in MFE culture medium. These compounds are structural analogs of antibiotics 273a2α and 273a2β containing a thiazole moiety, probably originated through an intramolecular Michael addition. The novel, thiazole, moiety-containing paulomycins show a lower antibiotic activity than paulomycins A and B against Gram-positive bacteria. However, two of them show an improved activity against Gram-negative bacteria. In addition, the four novel compounds are more stable in culture than paulomycins A and B. Thus, the presence of an N-acetyl-l-cysteine moiety linked to the carbon atom of the paulic acid isothiocyanate moiety, via a thioester bond, and the subsequent intramolecular cyclization of the paulic acid to generate a thiazole heterocycle confer to paulomycins a higher structural stability that otherwise will conduce to paulomycin degradation and into inactive paulomenols. View Full-Text
机译:已从在MFE培养基中生长的S. albus J1074分离了四种新的霉素霉素衍生物。这些化合物是含有噻唑部分的抗生素273a2α和273a2β的结构类似物,可能是由于分子内迈克尔加成而产生的。新型的含有噻唑部分的保罗霉素对革兰氏阳性细菌的抗菌活性低于保罗霉素A和B。然而,它们中的两个显示出对革兰氏阴性细菌的改善的活性。另外,这四种新化合物在培养中比泡霉素A和B更稳定。因此,存在通过硫酯键与泡桐酸异硫氰酸酯部分的碳原子连接的N-乙酰-1-半胱氨酸部分,以及随后的果酸的分子内环化反应产生噻唑杂环,使噻菌素具有更高的结构稳定性,否则该结构稳定性将导致菌素降解并转化为非活性的果香酚。查看全文

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号